This company listing is no longer active
Ascendis Health Management
Management criteria checks 3/4
Ascendis Health's CEO is A. Neethling, appointed in Sep 2022, has a tenure of 3.25 years. total yearly compensation is ZAR1.87M, comprised of 98.9% salary and 1.1% bonuses, including company stock and options. directly owns 16.21% of the company’s shares, worth ZAR93.33M. The average tenure of the management team and the board of directors is 1.8 years and 3.4 years respectively.
Key information
A. Neethling
Chief executive officer
R1.9m
Total compensation
| CEO salary percentage | 98.93% |
| CEO tenure | 3.3yrs |
| CEO ownership | 16.2% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.4yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | R2m | R2m | R11m |
| Mar 31 2025 | n/a | n/a | R15m |
| Dec 31 2024 | n/a | n/a | R18m |
| Sep 30 2024 | n/a | n/a | R30m |
| Jun 30 2024 | R2m | R2m | R42m |
| Mar 31 2024 | n/a | n/a | -R4m |
| Dec 31 2023 | n/a | n/a | -R51m |
| Sep 30 2023 | n/a | n/a | -R168m |
| Jun 30 2023 | R81k | n/a | -R286m |
| Mar 31 2023 | n/a | n/a | -R277m |
| Dec 31 2022 | n/a | n/a | -R268m |
| Sep 30 2022 | n/a | n/a | -R513m |
| Jun 30 2022 | R67k | n/a | -R759m |
Compensation vs Market: A.'s total compensation ($USD109.72K) is below average for companies of similar size in the ZA market ($USD403.53K).
Compensation vs Earnings: A.'s compensation has been consistent with company performance over the past year.
CEO
A. Neethling (46 yo)
Mr. A. Carl Neethling is CEO & Executive Director of Ascendis Health Limited from 2023 and had been its Acting Chief Financial Officer. He served as Executive Director, Chief Transition Officer and Acting...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.3yrs | R1.87m | 16.21% ZAR 93.3m | |
| CFO & Executive Director | 1.4yrs | R5.06m | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Head of Legal & Group Company Secretary | 2.3yrs | no data | no data |
Experienced Management: ASC's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.6yrs | R1.87m | 16.21% ZAR 93.3m | |
| CFO & Executive Director | 1yr | R5.06m | no data | |
| Independent Non-Executive Chairman | 3.6yrs | R800.00k | 0.040% ZAR 230.5k | |
| Independent Non-Executive Director | 4yrs | R440.00k | 0.20% ZAR 1.2m | |
| Independent Non-Executive Director | 3.6yrs | R593.00k | no data | |
| Non-Executive Director | 3.2yrs | R219.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | R367.00k | no data | |
| Independent Non-executive Director | less than a year | no data | no data |
Experienced Board: ASC's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/08 03:38 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ascendis Health Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marcelle Jankelow | Investec Bank plc (UK) |